129 related articles for article (PubMed ID: 31138612)
1. Deletion of a 19-Amino-Acid Region in Clostridioides difficile TcdB2 Results in Spontaneous Autoprocessing and Reduced Cell Binding and Provides a Nontoxic Immunogen for Vaccination.
Bland SJ; Larabee JL; Shadid TM; Lang ML; Ballard JD
Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31138612
[No Abstract] [Full Text] [Related]
2. Amino Acid Differences in the 1753-to-1851 Region of TcdB Influence Variations in TcdB1 and TcdB2 Cell Entry.
Hunt JJ; Larabee JL; Ballard JD
mSphere; 2017; 2(4):. PubMed ID: 28776043
[No Abstract] [Full Text] [Related]
3. Memory B Cells Encode Neutralizing Antibody Specific for Toxin B from the Clostridium difficile Strains VPI 10463 and NAP1/BI/027 but with Superior Neutralization of VPI 10463 Toxin B.
Devera TS; Lang GA; Lanis JM; Rampuria P; Gilmore CL; James JA; Ballard JD; Lang ML
Infect Immun; 2016 Jan; 84(1):194-204. PubMed ID: 26502913
[TBL] [Abstract][Full Text] [Related]
4. Intrinsic Toxin-Derived Peptides Destabilize and Inactivate
Larabee JL; Bland SJ; Hunt JJ; Ballard JD
mBio; 2017 May; 8(3):. PubMed ID: 28512094
[No Abstract] [Full Text] [Related]
5. Clostridium difficile chimeric toxin receptor binding domain vaccine induced protection against different strains in active and passive challenge models.
Tian JH; Glenn G; Flyer D; Zhou B; Liu Y; Sullivan E; Wu H; Cummings JF; Elllingsworth L; Smith G
Vaccine; 2017 Jul; 35(33):4079-4087. PubMed ID: 28669616
[TBL] [Abstract][Full Text] [Related]
6. A sequence invariable region in TcdB2 is required for toxin escape from
Kempher ML; Shadid TM; Larabee JL; Ballard JD
J Bacteriol; 2024 Jun; ():e0009624. PubMed ID: 38888328
[TBL] [Abstract][Full Text] [Related]
7. Functional analyses of epidemic Clostridioides difficile toxin B variants reveal their divergence in utilizing receptors and inducing pathology.
Pan Z; Zhang Y; Luo J; Li D; Zhou Y; He L; Yang Q; Dong M; Tao L
PLoS Pathog; 2021 Jan; 17(1):e1009197. PubMed ID: 33507919
[TBL] [Abstract][Full Text] [Related]
8. Cell-penetrating peptides derived from
Larabee JL; Hauck GD; Ballard JD
J Biol Chem; 2018 Feb; 293(5):1810-1819. PubMed ID: 29247010
[No Abstract] [Full Text] [Related]
9. Exposure of neutralizing epitopes in the carboxyl-terminal domain of TcdB is altered by a proximal hypervariable region.
Larabee JL; Krumholz A; Hunt JJ; Lanis JM; Ballard JD
J Biol Chem; 2015 Mar; 290(11):6975-85. PubMed ID: 25614625
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of the enzymatic domain of Clostridium difficile toxin B reveals novel inhibitors of the wild-type toxin.
Spyres LM; Daniel J; Hensley A; Qa'Dan M; Ortiz-Leduc W; Ballard JD
Infect Immun; 2003 Jun; 71(6):3294-301. PubMed ID: 12761111
[TBL] [Abstract][Full Text] [Related]
11. Critical roles of Clostridium difficile toxin B enzymatic activities in pathogenesis.
Li S; Shi L; Yang Z; Zhang Y; Perez-Cordon G; Huang T; Ramsey J; Oezguen N; Savidge TC; Feng H
Infect Immun; 2015 Feb; 83(2):502-13. PubMed ID: 25404023
[TBL] [Abstract][Full Text] [Related]
12. Clostridium difficile Toxin B causes epithelial cell necrosis through an autoprocessing-independent mechanism.
Chumbler NM; Farrow MA; Lapierre LA; Franklin JL; Haslam DB; Goldenring JR; Lacy DB
PLoS Pathog; 2012; 8(12):e1003072. PubMed ID: 23236283
[TBL] [Abstract][Full Text] [Related]
13. Identification of an Essential Region for Translocation of Clostridium difficile Toxin B.
Chen S; Wang H; Gu H; Sun C; Li S; Feng H; Wang J
Toxins (Basel); 2016 Aug; 8(8):. PubMed ID: 27537911
[TBL] [Abstract][Full Text] [Related]
14. Systemic antibody responses induced by a two-component Clostridium difficile toxoid vaccine protect against C. difficile-associated disease in hamsters.
Anosova NG; Brown AM; Li L; Liu N; Cole LE; Zhang J; Mehta H; Kleanthous H
J Med Microbiol; 2013 Sep; 62(Pt 9):1394-1404. PubMed ID: 23518659
[TBL] [Abstract][Full Text] [Related]
15. Variations in TcdB activity and the hypervirulence of emerging strains of Clostridium difficile.
Lanis JM; Barua S; Ballard JD
PLoS Pathog; 2010 Aug; 6(8):e1001061. PubMed ID: 20808849
[TBL] [Abstract][Full Text] [Related]
16. TcdB from hypervirulent Clostridium difficile exhibits increased efficiency of autoprocessing.
Lanis JM; Hightower LD; Shen A; Ballard JD
Mol Microbiol; 2012 Apr; 84(1):66-76. PubMed ID: 22372854
[TBL] [Abstract][Full Text] [Related]
17. Functional defects in
Gupta P; Zhang Z; Sugiman-Marangos SN; Tam J; Raman S; Julien JP; Kroh HK; Lacy DB; Murgolo N; Bekkari K; Therien AG; Hernandez LD; Melnyk RA
J Biol Chem; 2017 Oct; 292(42):17290-17301. PubMed ID: 28842504
[No Abstract] [Full Text] [Related]
18. Vaccination against
Winter K; Xing L; Kassardjian A; Ward BJ
Infect Immun; 2019 Aug; 87(8):. PubMed ID: 31138615
[No Abstract] [Full Text] [Related]
19. Identification of TFPI as a receptor reveals recombination-driven receptor switching in Clostridioides difficile toxin B variants.
Tian S; Xiong X; Zeng J; Wang S; Tremblay BJ; Chen P; Chen B; Liu M; Chen P; Sheng K; Zeve D; Qi W; Breault DT; Rodríguez C; Gerhard R; Jin R; Doxey AC; Dong M
Nat Commun; 2022 Nov; 13(1):6786. PubMed ID: 36351897
[TBL] [Abstract][Full Text] [Related]
20. Oral Immunization with Nontoxigenic Clostridium difficile Strains Expressing Chimeric Fragments of TcdA and TcdB Elicits Protective Immunity against C. difficile Infection in Both Mice and Hamsters.
Wang Y; Wang S; Bouillaut L; Li C; Duan Z; Zhang K; Ju X; Tzipori S; Sonenshein AL; Sun X
Infect Immun; 2018 Nov; 86(11):. PubMed ID: 30150259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
